Рет қаралды 275
Karin Rosén, M.D, PhD, was elected as a new member of the Board at Diamyd Medical’s Annual General Meeting held on November 30, 2023. In this video introduction, she talks about her experience from working in commercial roles within the pharmaceutical industry in the United States, the importance of the US market and what motivates her to support Diamyd Medical’s work to develop new and innovative medicines for treating type 1 diabetes. The video is in Swedish and subtitled in English.
www.diamyd.com